Moreover, in the HCC model, ExoASO‐STAT6 showed significant antitumoral efficacy, which suggested that tumours located in the liver, including primary liver cancer or liver metastasis of other tumour types, can benefit from treatment with ExoASO‐STAT6.136. Here, STAT6 is linked to neoplasm.